Diagnostic Medical Systems S.A.
ALDMS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €23,600 | €23,225 | €22,875 | €986 |
| % Growth | 1.6% | 1.5% | 2,220% | – |
| Cost of Goods Sold | €0 | €4,267 | €23,410 | -€7,590 |
| Gross Profit | €0 | €18,927 | -€535 | €8,576 |
| % Margin | 0% | 81.5% | -2.3% | 869.8% |
| R&D Expenses | €0 | €0 | €2,130 | €1,267 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | -€1,994 | €8,138 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €24,600 | €18,562 | €40 | €2,341 |
| Operating Expenses | €24,600 | €18,562 | €176 | €11,746 |
| Operating Income | -€2,200 | €365 | -€711 | -€1,344 |
| % Margin | -9.3% | 1.6% | -3.1% | -136.3% |
| Other Income/Exp. Net | €2,200 | €0 | -€660 | €3,170 |
| Pre-Tax Income | €0 | -€1,240 | -€1,371 | -€13,715 |
| Tax Expense | €0 | €186 | €19 | €2 |
| Net Income | -€100 | -€1,510 | -€1,432 | €4,818 |
| % Margin | -0.4% | -6.5% | -6.3% | 488.6% |
| EPS | -0.011 | -0.081 | -0.089 | -0.81 |
| % Growth | 86.8% | 8.7% | 89% | – |
| EPS Diluted | -0.011 | -0.081 | -0.089 | -0.81 |
| Weighted Avg Shares Out | 18,619 | 18,619 | 16,125 | 16,633 |
| Weighted Avg Shares Out Dil | 18,619 | 18,619 | 16,125 | 16,633 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €0 | €0 | €0 |
| Interest Expense | €300 | €1,972 | €328 | €296 |
| Depreciation & Amortization | €1,200 | €1,286 | €1,287 | €1,158 |
| EBITDA | -€1,000 | -€23,194 | €244 | -€642 |
| % Margin | -4.2% | -99.9% | 1.1% | -65.1% |